Main Article Content
Hematogone hyperplasia is seen in many reactive and neoplastic conditions such as autoimmune cytopenia(s), post viral infections, Hodgkin/ Non Hodgkin lymphoma, acute myeloid leukaemia, post chemotherapy or stem cell transplant bone marrow. However, occasionally a marked reactive process like hematogone hyperplasia can mask an important underlying morphology. It is further compounded in cases where the diagnostic cells are few in number. Clinching a diagnosis in such cases becomes increasingly difficult.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
 Chantepie SP, Cornet E, Sala¨un V, et al. Hematogones: an overview. Leukemia Research, 2013, 37(11): 1404-1411. https://doi.org/10.1016/j.leukres.2013.07.024
 Richard G, Brody J and Sun T. A case of acute megakaryocytic leukemia with hematogones. Leukemia, 1993, 7(11): 1900-1903.
 Anton-Harisi M, Douna V, Baka M, et al. Acute megakaryoblastic leukemia with increased hematogones in children. Journal of Pediatric Hematology/Oncology, 2012, 34(8): e337-e340. https://doi.org/10.1097/MPH.0b013e3182678ddb
 Chaudhari J, Borges A, Bansal S, et al. AML M7 Misdiagnosed as ALL. Indian Journal of Hematology and Blood Transfusion, 2014, 30(Suppl 1): 199-201. https://doi.org/10.1007/s12288-013-0326-4
 Rack KA, van den Berg E, Haferlach C, et al. European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms. Leukemia, 2019, 33(8): 1851-1867. https://doi.org/10.1038/s41375-019-0378